We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
-14.15%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$69.6B
AUM Growth
-$16.5B
Cap. Flow
-$3.3B
Cap. Flow %
-4.75%
Top 10 Hldgs %
17.71%
Holding
779
New
83
Increased
294
Reduced
313
Closed
76

Top Sells

Rank Stock Value
1
ANDV
Andeavor
ANDV
+$1.05B
2
MRK icon
Merck
MRK
+$702M
3
BAC icon
Bank of America
BAC
+$542M
4
ORCL icon
Oracle
ORCL
+$528M
5
STLD icon
Steel Dynamics
STLD
+$499M

Sector Composition

Rank Sector Weight
1 Financials 26.74%
2 Healthcare 14.95%
3 Industrials 13.38%
4 Technology 12.24%
5 Energy 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ETR icon
101
Entergy
ETR
$49.7B
$205M 0.29%
4,764,736
-1,221,432
-20% -$52M
WRB icon
102
W.R. Berkley
WRB
$25.4B
$202M 0.29%
9,226,504
-3,445,328
-27% -$77.4M
EWBC icon
103
East-West Bancorp
EWBC
$17.8B
$200M 0.29%
4,587,737
-1,309,518
-22% -$67.9M
NOMD icon
104
Nomad Foods
NOMD
$1.68B
$198M 0.28%
11,830,603
+464,523
+4% +$8.83M
TSE
105
DELISTED
Trinseo
TSE
$195M 0.28%
4,252,360
+1,108,894
+35% +$60.3M
BFH icon
106
Bread Financial
BFH
$4.15B
$193M 0.28%
1,611,398
+337,603
+27% +$52.9M
DRE
107
DELISTED
Duke Realty Corp.
DRE
$192M 0.28%
7,412,866
+190,422
+3% +$5.28M
CX icon
108
Cemex
CX
$15.8B
$191M 0.27%
39,597,329
-13,952,635
-26% -$74.4M
PEP icon
109
PepsiCo
PEP
$191B
$191M 0.27%
1,725,840
+340,447
+25% +$38.4M
LHX icon
110
L3Harris
LHX
$48.8B
$188M 0.27%
1,395,283
-45,939
-3% -$6.94M
RJF icon
111
Raymond James Financial
RJF
$33.9B
$187M 0.27%
3,776,222
-1,929,021
-34% -$103M
CRH icon
112
CRH
CRH
$63.6B
$186M 0.27%
7,074,834
-181,248
-2% -$5.13M
WCC
113
WESCO International
WCC
$17.1B
$186M 0.27%
3,876,768
-478,600
-11% -$24.8M
UPS icon
114
United Parcel Service
UPS
$89.9B
$184M 0.27%
1,891,319
+1,834,692
+3,240% +$199M
DTE icon
115
DTE Energy
DTE
$28.3B
$183M 0.26%
1,952,858
-105,979
-5% -$10.3M
ETFC
116
DELISTED
E*Trade Financial Corporation
ETFC
$180M 0.26%
4,092,445
+770,524
+23% +$37.8M
RNR icon
117
RenaissanceRe
RNR
$13.7B
$179M 0.26%
1,340,903
+792,675
+145% +$103M
ICLR icon
118
Icon
ICLR
$13.1B
$178M 0.26%
1,378,306
-184,993
-12% -$25.6M
WRK
119
DELISTED
WestRock Company
WRK
$169M 0.24%
4,470,597
-1,471,612
-25% -$64.9M
SLM icon
120
SLM Corp
SLM
$5.03B
$167M 0.24%
20,096,094
-4,620,699
-19% -$46M
ABT icon
121
Abbott
ABT
$193B
$166M 0.24%
2,295,996
-291,628
-11% -$20.5M
DEI icon
122
Douglas Emmett
DEI
$1.99B
$166M 0.24%
4,863,493
+124,093
+3% +$4.46M
GOOG icon
123
Alphabet (Google) Class C
GOOG
$4.13T
$166M 0.24%
3,204,560
+623,560
+24% +$33.4M
DNB
124
DELISTED
Dun & Bradstreet
DNB
$163M 0.23%
1,144,164
-64,050
-5% -$9.13M
JAZZ icon
125
Jazz Pharmaceuticals
JAZZ
$16.3B
$163M 0.23%
1,315,371
+198,306
+18% +$29.4M

Similar funds

Boston Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Boston Partners held 779 positions worth $69.6B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners withdrew a net $3.3B in Q4 2018, closing 76 positions and reducing 313 holdings. Its most notable exit was Andeavor, an estimated $1.05B position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Boston Partners opened a new position in Procter & Gamble worth $775M.

  • Boston Partners's largest Q4 2018 buy was Procter & Gamble: 8,428,522 shares worth $775M.
  • Boston Partners added most to Marathon Petroleum in Q4 2018, an estimated $374M increase.
  • Boston Partners's biggest Q4 2018 reduction was Merck, cutting an estimated $702M.
  • Boston Partners fully exited Andeavor in Q4 2018, selling an estimated $1.05B.
  • Boston Partners's ten largest holdings make up 18% of its $69.6B portfolio in Q4 2018.
  • Boston Partners opened 83 new positions and closed 76 in Q4 2018.
  • Boston Partners's portfolio value fell 19% quarter-over-quarter to $69.6B.

Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.